Similarly, high expression levels of the ATP synthase inhibitory factor 1 (IF1), which inhibits the activity of the mitochondrial ATP synthase, predicts a better outcome for breast cancer patients, especially in the case of triple-negative breast cancer (83, 84). This evidence concerns the gene ATP5IF1 and breast cancer.